(Q34156602)

31 July 2017

PET/SPECT imaging agents for neurodegenerative diseases (English)

1 reference

31 July 2017

1 reference

Lin Zhu

1

1 reference

PubMed ID

24676152

31 July 2017

Karl Ploessl

series ordinal

2

1 reference

PubMed ID

24676152

31 July 2017

Hank F Kung

series ordinal

3

1 reference

31 July 2017

1 October 2014

1 reference

31 July 2017

Chemical Society Reviews

1 reference

31 July 2017

43

1 reference

31 July 2017

6683-6691

1 reference

31 July 2017

19

1 reference

The β-Amyloid Hypothesis in Alzheimer's Disease: Seeing Is Believing

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Molecular imaging as a guide for the treatment of central nervous system disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Development and screening of contrast agents for in vivo imaging of Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Bapineuzumab and solanezumab for Alzheimer's disease: is the 'amyloid cascade hypothesis' still alive?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

The impact of DaTscan on the diagnosis and management of movement disorders: A retrospective study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

The future of USP monographs for PET drugs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Development of positron emission tomography β-amyloid plaque imaging agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Neuroimaging over the course of Parkinson's disease: from early detection of the at-risk patient to improving pharmacotherapy of later-stage disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Imaging biomarkers in Parkinson's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and Alzheimer disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

The use of PET in Alzheimer disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Molecular imaging with PET.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

PET versus SPECT: strengths, limitations and challenges

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Molecular imaging in cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

[3H]dihydrotetrabenazine, a new in vitro monoaminergic probe for human brain

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Trends in nuclear medicine in developing countries.

5 July 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Translational PET imaging research

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Molecualr imaging of cancer: from molecules to humans. Introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Chemistry. Expanding the scope of fluorine tags for PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Against

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Striatal concentrations of vesicular monoamine transporters are identical in MPTP-sensitive (C57BL/6) and -insensitive (CD-1) mouse strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

Novel stilbenes as probes for amyloid plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3CS60430F

FDA cGMP requirements for PET drugs.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4159420

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution

28 October 2018

1 reference

12 December 2020

Alzheimer’s drugs take a new tack

1 reference

12 December 2020

A shielded synthesis system for production of 2-deoxy-2-[18F]fluoro-D-glucose

1 reference

12 December 2020

Potential technetium small molecule radiopharmaceuticals

1 reference

12 December 2020

Identifiers

DOI

10.1039/C3CS60430F

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

PubMed ID

24676152